Immunology/Inflammation
-   B6514 NS 398Summary: Selective cyclooxygenase-2 (COX-2) inhibitor B6514 NS 398Summary: Selective cyclooxygenase-2 (COX-2) inhibitor
-   B5662 Pam3CSK4 TFASummary: A toll-like receptor 1/2 (TLR1/2) agonist B5662 Pam3CSK4 TFASummary: A toll-like receptor 1/2 (TLR1/2) agonist
-   C8437 Licoricesaponin G2Summary: A triterpenoid saponin compound extracted from licorice C8437 Licoricesaponin G2Summary: A triterpenoid saponin compound extracted from licorice
-   A9923 Cinnamic acidSummary: An aromatic unsaturated carboxylic acid A9923 Cinnamic acidSummary: An aromatic unsaturated carboxylic acid
-   A9934 Zymosan ASummary: A polysaccharide compound extracted from the cell wall of yeast A9934 Zymosan ASummary: A polysaccharide compound extracted from the cell wall of yeast
-   A9964 cis-11-Octadecenoic acidSummary: A monounsaturated fatty acid with 18 carbon atoms A9964 cis-11-Octadecenoic acidSummary: A monounsaturated fatty acid with 18 carbon atoms
-   A9966 11Z,14Z-Eicosadienoic acidSummary: A polyunsaturated fatty acid containing 20 carbon atoms A9966 11Z,14Z-Eicosadienoic acidSummary: A polyunsaturated fatty acid containing 20 carbon atoms
-   A9982 Vipivotide tetraxetanSummary: A potent prostate-specific membrane antigen (PSMA) inhibitor A9982 Vipivotide tetraxetanSummary: A potent prostate-specific membrane antigen (PSMA) inhibitor
-   A9995 Agatolimod sodiumSummary: A synthetic oligodeoxynucleotide (ODN) that acts as a TLR9 agonist A9995 Agatolimod sodiumSummary: A synthetic oligodeoxynucleotide (ODN) that acts as a TLR9 agonist
-   A9998 Uric acid sodiumSummary: An important antioxidant with the ability to scavenge oxygen radicals A9998 Uric acid sodiumSummary: An important antioxidant with the ability to scavenge oxygen radicals
